Faster diagnosis and equitable care across Europe
European Patient Alliance for Timely Diagnosis (example) · NGO / civil society · European Union
01The change we want next
Secure an EU-level commitment to measurable diagnostic pathways, meaningful patient involvement and stronger cross-border coordination in the next health work programme.
- Main request
- Fund a multi-country diagnostic pathway initiative with common access indicators, patient-reported outcomes and formal patient-organisation participation in design and oversight.
- Who can say yes
- European Commission
- Useful timing
- Before the next EU health work programme and national implementation priorities are finalised
- Good alternative
- Launch funded pilots in willing Member States with shared measures and a commitment to scale what works.
- Non-negotiable
- Patient participation must be substantive, accessible and funded—not limited to one-off consultation after decisions are already made.
02Why they should act
- The problem
- Decision-makers recognise diagnostic delay, but may see it as a collection of national service problems rather than a cross-border access and coordination challenge.
- What matters to them
- They need a focused initiative that respects national health-system responsibilities, shows European added value and can demonstrate progress without creating heavy new structures.
- Wider benefit
- Earlier, more accurate diagnosis reduces avoidable harm and uncertainty, helps people reach appropriate care sooner and makes better use of scarce specialist expertise across Europe.
- Best evidence
- Patient journey evidence, diagnostic-delay data and practical experience from specialist networks can show where people fall through gaps and which referral approaches improve access.
- Best voice
- Patient, beneficiary or affected person
- Likely concern
- Healthcare delivery is primarily national, and a new EU initiative could duplicate existing networks or create reporting burdens without changing access.
- Our answer
- The proposal uses existing specialist networks and national services. EU support adds value by aligning measures, spreading workable pathways and making cross-border expertise easier to reach.
03People and organisations that matter
National health ministries and payersAddress concerns now
Gatekeeper · Influences · Power 5/5 · Sceptical · Relationship: Weak
What may help: Evidence of feasibility, affordability and respect for national health-system responsibilities.European Commission — DG Health & Food SafetyFocus now
Decision-maker · Decides · Power 5/5 · Undecided · Relationship: Developing
What may help: A focused and deliverable proposal with clear European added value, measurable outcomes and Member State support.European Parliament — SANT CommitteeWork with closely
Political sponsor · Amplifies · Power 4/5 · Supportive · Relationship: Developing
What may help: A human story, clear equity case and specific commitment they can champion.European Reference Networks and specialist cliniciansWork with closely
Implementer · Advises · Power 4/5 · Supportive · Relationship: Developing
What may help: Workable pathways, adequate capacity and measures that improve care rather than add reporting burden.National and condition-specific patient organisationsBring in as an ally
Ally · Amplifies · Power 3/5 · Champion · Relationship: Established
What may help: A meaningful role, accessible participation and confidence that diverse patient experiences are represented.People awaiting diagnosis and family carersBring in as an ally
Affected group · Amplifies · Power 3/5 · Champion · Relationship: Established
What may help: A safe and supported way to share experience, visible benefits and feedback on how their input changes decisions.04Who does what, and when
1. Validate the shared ask with national and condition-specific patient groupsIn progress
Next 30 days · Owner: Coalition lead
For: National and condition-specific patient organisations · Format: Coalition2. Present a concise patient-journey and indicator briefing to programme officialsPlanned
30–60 days · Owner: Policy lead
For: European Commission — DG Health & Food Safety · Format: Technical briefing3. Test delivery feasibility and reporting burden with clinical networksPlanned
30–60 days · Owner: Technical / scientific lead
For: European Reference Networks and specialist clinicians · Format: Direct meeting4. Equip parliamentary champions with patient stories, safeguards and a specific programme askPlanned
60–90 days · Owner: Public affairs lead
For: European Parliament — SANT Committee · Format: Direct meeting05Progress and risks
- Success
- The work programme includes funded action on diagnostic pathways, common equity and access indicators, and a defined decision-making role for patient organisations.
- Early signs
- Commission officials reuse the access framing; several Member States support pilots; patient participation is written into programme design; implementers agree on a small common indicator set.
- Next review
- 2026-10-15
The alliance is challenged on whether it represents the diversity of patient experienceScore 6
Publish clear participation criteria, involve smaller national groups, reimburse participation and show how dissenting views were handled.
Owner: Coalition leadHealth ministries see the proposal as an unfunded expansion of national obligationsScore 6
Lead with funded pilots, a limited common indicator set and evidence that earlier diagnosis can reduce avoidable system costs.
Owner: Policy leadPatient stories are used tokenistically or without adequate consent and supportScore 3
Use informed consent, safeguarding, compensation and patient control over how personal experience is presented.
Owner: Communications lead06Sources to check
No external sources selected.